Clinical Manual for Diagnosis, Prevention and Treatment of Cardiovascular Complications of Cancer Therapy. Parts II-V

Clinical Manual for Diagnosis, Prevention and Treatment of Cardiovascular Complications of Cancer Therapy. Parts II-V

Advances in treatment have led to improved survival of patients with cancer but have also resulted in untoward side effects associated with treatment. Cardiovascular diseases are one of the most frequent of these side effects. Myocardial dysfunction and heart failure, myocardial ischaemia, arrhythmi...

Full description

Bibliographic Details
Main Authors:	I Ye Chazova, S A Tyulyandin, M V Vitsenia, M G Poltavskaya, M Yu Gilyarov, T V Martynyuk, A G Ovchinnikov, E P Panchenko, Yu A Fedotkina, M B Stenina, O P Trophimova, F T Ageev
Format:	Article
Language:	Russian
Published:	IP Morozov P.V. 2017-12-01
Series:	Системные гипертензии
Subjects:	cardiotoxicity chemotherapy coronary artery disease arterial hypertension arrhythmias pulmonary hypertension diagnosis prevention treatment
Online Access:	https://syst-hypertension.ru/2075-082X/article/viewFile/29199/pdf

Similar Items

Clinical Manual for Diagnosis, Prevention and Treatment of Cardiovascular Complications of Cancer Therapy. Parts II–V
by: Chazova I.Ye., et al.
Published: (2017-11-01)

Clinical manual for diagnosis, prevention and treatment of cardiovascular complications of cancer therapy. Parts VI-VII
by: I Ye Chazova, et al.
Published: (2018-03-01)

Clinical Manual for Diagnosis, Prevention and Treatment of Cardiovascular Complications of Cancer Therapy. Part I
by: I Ye Chazova, et al.
Published: (2017-12-01)

Evaluation of subclinical cardiotoxicity in patients with breast cancer and arterial hypertension in two regimens of anthracycline-containing chemotherapy
by: A A Avalyan, et al.
Published: (2018-12-01)

Uncontrolled arterial hypertension in patients with breast cancer and the risk of developing cardiotoxicity with anthracycline-containing chemotherapy
by: Elena V Oshchepkova, et al.
Published: (2019-12-01)

Markers of early cardiotoxicity in patients with breast cancer undergoing chemotherapy depending on blood pressure level
by: A A Avalyan, et al.
Published: (2017-12-01)

Clinical manual for diagnosis, prevention and treatment of cardiovascular complications of cancer therapy. Parts VI–VII
by: Chazova I.Ye., et al.
Published: (2018-02-01)

Speckle-tracking echocardiography in 3D mode in assessing the deformation of the myocardium and identifying subclinical cardiotoxicity during chemotherapy in breast cancer patients with arterial hypertension
by: Ani A. Avalyan, et al.
Published: (2020-10-01)

Clinical Manual for Diagnosis, Prevention and Treatment of Cardiovascular Complications of Cancer Therapy. Part I
by: Chazova I.Ye., et al.
Published: (2017-09-01)

Effectiveness of ACE inhibitor ramipril and its combination with hydrochlorothiazide in patients with arterial hypertension and overweight: CHARISMA Study
by: I. P. Kolos, et al.
Published: (2008-04-01)

The vascular wall in postmenopausal women with hypothyroidism and hypertension
by: O Iu Riabtseva, et al.
Published: (2013-10-01)

Pulmonary arterial hypertension in Russia: six-year observation analysis of the National Registry
by: I E Chazova, et al.
Published: (2019-01-01)

The development of a screening questionnaire to improve the early detection of pulmonary arterial hypertension
by: Z S Valieva, et al.
Published: (2014-12-01)

Arterial hypertension and stress-induced arrhythmias in coronary heart disease patients
by: L. A. Leshchinsky, et al.
Published: (2005-06-01)

Antihypertensive therapy in men and women in real clinical practice according to the National register
by: E V Oshhepkova, et al.
Published: (2019-09-01)

Renal denervation with a resistant arterial hypertension: the results of a five-year follow-up
by: P V Glybochko, et al.
Published: (2018-09-01)

New horizons for the use of the second generation of endothelin receptor antagonist macitentan in patients with pulmonary hypertension
by: T V Martynyuk, et al.
Published: (2018-04-01)

Clinical effectiveness of magnesium orotate in patients with cardiac arrhythmias, arterial hypertension, and mitral valve prolapse
by: E. V. Akatova, et al.
Published: (2009-08-01)

Chronic obstructive pulmonary disease and associated illnesses
by: A G Chuchalin
Published: (2008-08-01)

Features of the clinics and treatment of patients with obesity and hypertension (according to the National register of arterial hypertension)
by: E V Oshchepkova, et al.
Published: (2018-09-01)

Arterial hypertension and chronic obstructive pulmonary disease: clinical characteristics and treatment efficasy (according to the national register of arterial hypertension)
by: I E Chazova, et al.
Published: (2019-03-01)

Risk Factors for Anthracycline-Induced Cardiotoxicity
by: Shuo Qiu, et al.
Published: (2021-09-01)

POTASSIUM AND MAGNESIUM DRUGS IN THE TREATMENT OF CARDIOVASCULAR DISEASES IN THE PRACTICE OF PRIMARY CARE PHYSICIAN
by: A. M. Shilov, et al.
Published: (2016-01-01)

Essential arterial hypertension risk factors, and their association in Kemerovo City penitentiary system personnel
by: A. V. Shabalin, et al.
Published: (2005-12-01)

ROLE OF HYPERTENSION AND SUPRAVENTRICULAR ARRHYTHMIAS IN COGNITIVE IMPAIRMENTS: THE CURRENT PROBLEM STATE
by: N. N. Kriukov, et al.
Published: (2015-09-01)

Efficacy of metoprolol in treatment and preventive of cardiovascular diseases
by: Irina Evgen'evna Chazova, et al.
Published: (2009-06-01)

THE EYE — MIRROR OF CARDIOVASCULAR DISORDERS. EVOLUTION OF PERCEPTION ABOUT HYPERTENSIVE RETINOPATHY
by: V. S. Zadionchenko, et al.
Published: (2016-01-01)

THE EYE — MIRROR OF CARDIOVASCULAR DISORDER. RELATIONSHIP OF THE RETINA FUNCTIONAL STATE AND THE HYPERTENSION SEVERITY
by: V. S. Zadionchenko, et al.
Published: (2016-01-01)

RENAL DENERVATION IN RESISTANT ARTERIAL HYPERTENSION
by: V. A. Sulimov, et al.
Published: (2015-09-01)

New horizons for the use of the second generation of endothelin receptor antagonist macitentan in patients with pulmonary hypertension
by: T.V. Martynyuk, et al.
Published: (2018-04-01)

Fixed-dose combination of perindopril and indapamide: perspectives in hypertensive patients with inadequately controlled blood pressure
by: I. E. Chazova, et al.
Published: (2007-02-01)

Relationship of daily arterial blood pressure monitoring readings and arterial stiffness profile in male patients with chronic obstructive pulmonary disease combined with arterial hypertension
by: Karoli N.A., et al.
Published: (2013-06-01)

Arterial hypertension in chronic glomerulonephritis:detectability and treatment efficacy
by: I M Kutyrina, et al.
Published: (2004-09-01)

Bosentan use in pulmonary arterial hypertension: Russian and foreign experience
by: Z S Valieva, et al.
Published: (2017-08-01)

Cerebrovascular events primary prevention in metabolic syndrome patients
by: V. B. Mychka, et al.
Published: (2006-04-01)

Cardiomyopathies and Arrhythmias Induced by Cancer Therapies
by: Dragoș-Mihai Romitan, et al.
Published: (2020-11-01)

Functional characteristics of microcirculation and their prognostic value in patients with arterial hypertension
by: A. P. Vasilyev, et al.
Published: (2011-10-01)

Radiofrequency renal arteries denervation: effectively and safely
by: V A Grigin, et al.
Published: (2016-12-01)

Radiofrequency renal arteries denervation: effectively and safely
by: Grigin V.A., et al.
Published: (2016-12-01)

Modern view on the place of riociguat in the treatment of pulmonary hypertension
by: Z S Valieva, et al.
Published: (2018-04-01)